Strides Pharma Science Limited (NSE:STAR)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical Business (Excl. Bio-Pharmaceutical Business)	48.59B	45.65B	38.90B	36.88B	30.70B
Total	48.59B	45.65B	38.90B	36.88B	30.70B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
North America	24.89B	24.51B	20.67B	19.26B	12.06B
Australia	5.08B	4.40B	3.65B	3.12B	3.17B
Africa	5.52B	4.62B	3.80B	4.51B	5.71B
Europe	10.27B	9.94B	8.66B	8.37B	6.77B
India	173.72M	159.56M	234.30M	218.63M	473.47M
Asia (Excluding India)	173.57M	225.46M	164.67M	460.56M	1.97B
Others	176.93M	76.43M	116.12M	143.94M	66.78M
Unallocated	2.31B	1.74B	1.60B	807.18M	481.94M
Total	48.59B	45.65B	38.90B	36.88B	30.70B

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error